<SEC-DOCUMENT>0001428336-21-000013.txt : 20210401
<SEC-HEADER>0001428336-21-000013.hdr.sgml : 20210401
<ACCEPTANCE-DATETIME>20210401163436
ACCESSION NUMBER:		0001428336-21-000013
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210401
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210401
DATE AS OF CHANGE:		20210401

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHEQUITY, INC.
		CENTRAL INDEX KEY:			0001428336
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36568
		FILM NUMBER:		21798551

	BUSINESS ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020
		BUSINESS PHONE:		801-727-1000

	MAIL ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHEQUITY INC
		DATE OF NAME CHANGE:	20080227
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hqy-20210401.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:0217b3d3-a373-4058-bbd4-1bd9038d62e9,g:1a9318c4-f7e3-4f6e-81d8-6a97cfe816dc,d:7572d5e3219b498fa20be5137c93bdb9--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hqy-20210401</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV80L2ZyYWc6MTFhNTE2NDNkZjdjNDZiMWFiZjQwY2M0ZTczN2ZhMjkvdGFibGU6YjdiOTBiY2I1MjQ4NDdjYjkxYTY3ZjY2NTljYWM2ZDUvdGFibGVyYW5nZTpiN2I5MGJjYjUyNDg0N2NiOTFhNjdmNjY1OWNhYzZkNV8yLTEtMS0xLTA_8241c5d1-c023-4d98-b283-4d5b4db98b4b">0001428336</ix:nonNumeric><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV80L2ZyYWc6MTFhNTE2NDNkZjdjNDZiMWFiZjQwY2M0ZTczN2ZhMjkvdGFibGU6YjdiOTBiY2I1MjQ4NDdjYjkxYTY3ZjY2NTljYWM2ZDUvdGFibGVyYW5nZTpiN2I5MGJjYjUyNDg0N2NiOTFhNjdmNjY1OWNhYzZkNV8zLTEtMS0xLTA_5492da65-eed3-4857-a918-22e06cb0bcaf">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hqy-20210401.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7572d5e3219b498fa20be5137c93bdb9_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">Form <ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF84Mw_20764cdf-05ed-4432-9b9c-22e523a9bc17">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">Date of Report (Date of earliest event reported)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yMjU_a2a96eaa-40a0-4ba6-9381-f29dea388d54">April 1, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.355%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6MjliZDRlOTQwMjNhNDczYzhlNmNkODE5ZWZiODg1NjYvdGFibGVyYW5nZToyOWJkNGU5NDAyM2E0NzNjOGU2Y2Q4MTllZmI4ODU2Nl8xLTAtMS0xLTA_5b8e1041-0bf0-40ea-8030-430406251b4e">HEALTHEQUITY, INC.</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:2.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6YjQwYjI5MDUyOGY5NGEwMTljNjM4NjdmNjQ2MmJhMzEvdGFibGVyYW5nZTpiNDBiMjkwNTI4Zjk0YTAxOWM2Mzg2N2Y2NDYyYmEzMV8wLTAtMS0xLTA_1bf2f753-21c7-4a9c-92d3-458b51b9f114">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6YjQwYjI5MDUyOGY5NGEwMTljNjM4NjdmNjQ2MmJhMzEvdGFibGVyYW5nZTpiNDBiMjkwNTI4Zjk0YTAxOWM2Mzg2N2Y2NDYyYmEzMV8wLTItMS0xLTA_1baad480-aae8-4c29-896f-8a0afe4f6ecb">001-36568</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6YjQwYjI5MDUyOGY5NGEwMTljNjM4NjdmNjQ2MmJhMzEvdGFibGVyYW5nZTpiNDBiMjkwNTI4Zjk0YTAxOWM2Mzg2N2Y2NDYyYmEzMV8wLTQtMS0xLTA_c6bff5e9-b6ba-404e-b9d7-c0798e5cac5f">52-2383166</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification Number)</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yMzc_756eabbb-7e1d-4acd-a835-ca405b25e180">15 West Scenic Pointe Drive</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNDE_a615dafd-dfdf-4b8e-9fa3-4ecb291c52bb">Suite 100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNDU_ebd0996c-6214-45c8-bcd7-68f80edae05e">Draper</ix:nonNumeric>, <ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNDk_28780fd8-c1a7-42c2-84b1-1208ca5b7ebb">Utah</ix:nonNumeric> <ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNTI_631ae561-5aa0-439a-b7f0-ca180b499db0">84020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNTc_4e1d3944-ee68-43a0-b52b-433c4ae251ac">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNjE_e7fd2d07-081b-4255-b562-5c467ca25646">727-1000</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(Address, including Zip Code, and Telephone Number, including Area Code, of Registrant&#8217;s Principal Executive Offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF82Njc_2a311fa3-3388-4be2-adf0-497a3dbc3a77">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF83NTY_1791ba19-e5a4-46b8-86ee-995244877d11">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF84NDY_47e532a4-437a-4772-aed6-e7e2570a4ae8">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF85NTI_d119c695-53e9-406f-92ab-082e58970f5c">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6OGVlMDk1ZWI4NmRiNGMwYThmMmI2NWU0MDlmMzcxODkvdGFibGVyYW5nZTo4ZWUwOTVlYjg2ZGI0YzBhOGYyYjY1ZTQwOWYzNzE4OV8xLTAtMS0xLTA_b44c2da9-4ee7-4c1a-9206-3740bf509f1d">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6OGVlMDk1ZWI4NmRiNGMwYThmMmI2NWU0MDlmMzcxODkvdGFibGVyYW5nZTo4ZWUwOTVlYjg2ZGI0YzBhOGYyYjY1ZTQwOWYzNzE4OV8xLTEtMS0xLTA_469d008b-6ad8-4e26-b09f-73a9c18db93a">HQY</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6OGVlMDk1ZWI4NmRiNGMwYThmMmI2NWU0MDlmMzcxODkvdGFibGVyYW5nZTo4ZWUwOTVlYjg2ZGI0YzBhOGYyYjY1ZTQwOWYzNzE4OV8xLTItMS0xLTA_53395819-c4b7-4bc1-802c-048f6b4eb55e">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8xMzY2_a673c8c4-271e-45e9-a959-3af10a1f5529">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%"> </span></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:138%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 5.02&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reported previously, effective April 1, 2021, Darcy Mott resigned as Executive Vice President and Chief Financial Officer of HealthEquity, Inc. (the &#8220;Company&#8221;). Mr. Mott will continue to act as a special advisor to the Company. Tyson Murdock succeeded Mr. Mott as the Company&#8217;s Executive Vice President and Chief Financial Officer effective April 1, 2021. Mr. Murdock will serve as the Company&#8217;s principal financial officer and principal accounting officer for purposes of filings with the Securities and Exchange Commission. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Murdock, age 49, joined the Company in January 2018 where he served as Senior Vice President and Corporate Controller until June 2020 and most recently as Executive Vice President and Deputy Chief Financial Officer from June 2020 to March 2021. Prior to joining the Company, Mr. Murdock worked in various roles at eBay, Inc. beginning in the San Jose, CA corporate headquarters in 2007 as part of the Mergers and Acquisitions team, followed by service in the Salt Lake City, Utah office as the Chief Financial Officer of eBay Marketplace&#8217;s Global Customer Experience division from February 2015 to January 2018. Prior to joining eBay, Inc., Mr. Murdock worked as a senior manager at Ernst &amp; Young LLP in the San Francisco Bay Area, serving a variety of public and private audit clients. Mr. Murdock holds a B.S. and a Master of Accountancy from Brigham Young University and is a Certified Public Accountant.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships between Mr. Murdock and any of the Company&#8217;s directors or executive officers, and there is no arrangement or understanding between Mr. Murdock or any other person and the Company or any of its subsidiaries pursuant to which he was appointed as an officer of the Company. There are no transactions between Mr. Murdock or any of his immediate family members and the Company or any of its subsidiaries that would be required to be reported under Item 404(a) of Regulation S-K. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously entered into a written employment agreement with Mr. Murdock, which was approved by the Company&#8217;s compensation committee.  Mr. Murdock&#8217;s employment agreement provides for &#8220;at-will&#8221; employment and does not have a stated duration or term. Under the terms of the employment agreement, Mr. Murdock is currently entitled to a base salary of not less than $350,000 and is eligible for an annual incentive bonus award with a target of 75% of Mr. Murdock&#8217;s base salary based upon the achievement of corporate and individual performance objectives as determined by the Company&#8217;s compensation committee. Under the terms of the employment agreement, Mr. Murdock previously received an award of restricted stock units with a fair market value of $550,000, which cliff vests following the expiration of the performance period ending January 31, 2023 based on the total shareholder return vesting metrics approved by the Company&#8217;s compensation committee on March 31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Murdock&#8217;s employment agreement also provides him with the opportunity to receive certain post-employment payments and benefits in the event of certain types of termination of his employment. Upon termination of Mr. Murdock's employment by the Company without &#8220;cause&#8221; (as defined in Mr. Murdock&#8217;s employment agreement) or by Mr. Murdock for &#8220;good reason&#8221; (as defined in Mr. Murdock&#8217;s employment agreement), in addition to any compensation that has been accrued or earned but not yet paid, subject to the execution of a general release of claims in favor of the Company and its affiliates, Mr. Murdock would be entitled to: (i) continued payment of his then current annual base salary for 12 months following the termination date; (ii) subject to the achievement of the applicable performance conditions for the relevant fiscal year, his annual bonus for the fiscal year in which the termination date occurs, pro-rated based on the number of days which elapsed in the applicable fiscal year through the date of termination, payable at such time annual bonuses are paid to our other executive officers; and (iii) subject to Mr. Murdock&#8217;s election of COBRA continuation coverage, provided he does not become eligible to receive comparable health benefits through a new employer, a monthly cash payment equal to the monthly COBRA premium cost for the 12-month period following the date of termination. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Mr. Murdock is terminated in connection with a change in control of the Company, he will be entitled to the severance benefits provided in the Company&#8217;s Amended and Restated Executive Change in Control Severance Plan (the &#8220;Severance Plan&#8221;), which provides for the same salary, bonus, and COBRA benefits described above. In addition, the vesting of all unvested equity awards will accelerate on a &#8220;double trigger&#8221; basis such that if Mr. Murdock&#8217;s employment with the Company is terminated by the Company without &#8220;cause&#8221; or by Mr. Murdock for &#8220;good reason&#8221; (each as defined in the Severance Plan), in each case, within the first 12-month period following a change in control of the Company in which Mr. Murdock&#8217;s equity awards are assumed or substituted for by the acquirer then, subject to all other terms and conditions set forth in the Severance Plan being met, any such assumed or substituted equity award held by Mr. Murdock that is then unvested will </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fully vest.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, upon a termination of Mr. Murdock&#8217;s employment due to death or &#8220;disability&#8221; (as defined in Mr. Murdock&#8217;s employment agreement), in addition to any accrued or earned but unpaid amounts, Mr. Murdock (or Mr. Murdock&#8217;s estate or beneficiaries, as the case may be) would be entitled to, subject to the achievement of the applicable </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance conditions for the relevant fiscal year, his annual bonus for the fiscal year in which the termination date occurs, pro-rated based on the number of days which elapsed in the applicable fiscal year through the date of termination, payable at such time annual bonuses are paid to our other executive officers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Murdock also signed a Confidentiality, Non-Interference, and Invention Assignment Agreement with the Company which subjects him to customary confidentiality restrictions that apply during his employment and indefinitely thereafter, a covenant not to compete during his employment, and for a period of 12 months thereafter, and a non-interference covenant while employed with us and for a period of 24 months thereafter. Generally, the non-compete provisions prevent Mr. Murdock from engaging in consumer healthcare related businesses, including the business of acting as custodian or administrator for medical payment reimbursement accounts and other consumer-directed benefits, including, but not limited to, health savings accounts, flexible spending accounts and health reimbursement accounts, COBRA administration, commuter and other benefits or any other business activities in which we or any of our affiliates are engaged (or have committed plans to engage) during his employment. The non-interference covenant prevents Mr. Murdock from soliciting or hiring our employees or those of our affiliates and from soliciting or inducing any of our customers, suppliers, licensees, or other business relations or those of our affiliates, to cease doing business with us, or reduce the amount of business conducted with us or our affiliates, or in any manner interfering with our relationships with such parties. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of Mr. Murdock&#8217;s employment agreement is qualified in its entirety by reference to the full text of the employment agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated by reference in this Item 5.02.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-tysonmurdockemp.htm">Employment Agreement between Tyson Murdock and the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (formatted in Inline XBRL)</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:49.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HEALTHEQUITY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 1, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Delano Ladd</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delano Ladd</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EVP, General Counsel and Secretary</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-tysonmurdockemp.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0f76bd84b6c44083a8681975deb767aa_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This EMPLOYMENT AGREEMENT (this&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made and entered into as of this 25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of June 2020, by and between HealthEquity, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and Tyson Murdock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">W I T N E S S E T H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company desires to enter into this Agreement to embody the terms of Executive&#8217;s continued employment, and Executive desires to enter into this Agreement and to accept the terms and provisions of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are mutually acknowledged, the Company and Executive hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Definitions.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (i)&#160;all accrued but unpaid Base Salary through the date of termination of Executive&#8217;s employment, (ii)&#160;any unpaid or unreimbursed expenses incurred in accordance with Section 7 hereof, and (iii)&#160;any benefits provided under the Company&#8217;s employee benefit plans upon a termination of employment, in accordance with the terms contained therein.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the preamble hereto.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 4(b) hereof.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the salary provided for in Section 4(a) hereof or any increased salary granted to Executive pursuant to Section 4(a) hereof.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (i)&#160;Executive&#8217;s act(s) of gross negligence or willful misconduct in the course of Executive&#8217;s employment hereunder&#59; (ii)&#160;willful failure or refusal by Executive to perform in any material respect Executive&#8217;s duties or responsibilities&#59; (iii)&#160;misappropriation (or attempted misappropriation) by Executive of any assets or business opportunities of the Company or any other member of the Company Group&#59; (iv)&#160;embezzlement or fraud committed (or attempted) by Executive, at Executive&#8217;s direction, or with Executive&#8217;s prior actual knowledge&#59; (v)&#160;Executive&#8217;s conviction of or pleading &#8220;guilty&#8221; or &#8220; no contest&#8221; to, (x)&#160;a felony or (y)&#160;any other criminal charge that has, or could be reasonably expected to have, an adverse impact on the performance of Executive&#8217;s duties to the Company or any other member of the Company Group or otherwise result in material injury to the reputation or business of the Company or any other member of the Company Group&#59; (vi)&#160;any material violation by Executive of the policies of the Company, including but not limited to those relating to sexual harassment, insider trading, or business conduct, and those otherwise set forth </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in the manuals or statements of policy of the Company&#59; or (vii)&#160;Executive&#8217;s material breach of this Agreement or breach of the Non-Interference Agreement.  </font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If, within ninety (90) days subsequent to Executive&#8217;s termination for any reason other than by the Company for Cause, the Company determines that Executive&#8217;s employment could have been terminated for Cause pursuant to subparts (i), (iii), (iv), or (v) of the preceding paragraph (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Post-Termination Cause Determination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Executive&#8217;s employment will be deemed to have been terminated for Cause for all purposes, and Executive will be required to disgorge to the Company all amounts received pursuant to this Agreement or otherwise on account of such termination that would not have been paid or payable to Executive had such termination been by the Company for Cause.  Notwithstanding the foregoing, the Company may assert a Post-Termination Cause Determination if, and only if, the Board did not have actual knowledge of facts supporting its Post-Termination Cause Determination prior to the termination of Executive&#8217;s employment. </font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean Part 6 of Title I of the Employee Retirement Income Security Act of 1974, as amended, and Section&#160;4980B of the Code, and the rules and regulations promulgated under any of them.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 2 hereof. </font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the preamble hereto.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Company together with any direct or indirect subsidiaries of the Company.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Board or the committee of the Board designated to make compensation decisions relating to senior executive officers of the Company Group.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Delay Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 13 hereof.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any physical or mental disability or infirmity of Executive that prevents the performance of Executive&#8217;s duties for a period of (i)&#160;ninety (90) consecutive days or (ii)&#160;one hundred twenty (120) non-consecutive days during any twelve (12) month period.  Any question as to the existence, extent, or potentiality of Executive&#8217;s Disability upon which Executive and the Company cannot agree shall be determined by a qualified, independent physician selected and paid for by the Company and approved by Executive (which approval shall not be unreasonably withheld).  The determination of any such physician shall be final and conclusive for all purposes of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the preamble hereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Executive Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Company&#8217;s Amended and Restated Executive Change in Control Severance Plan, as may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, without Executive&#8217;s consent, (i)&#160;a material diminution in Executive&#8217;s title, duties, or responsibilities as set forth in Section 3 hereof such that Executive is no longer serving in a senior executive capacity for the Company, (ii)&#160;a material reduction in Base Salary set forth in Section 4(a) hereof or Annual Bonus opportunity set forth in Section 4(b) hereof (other than pursuant to an across-the-board reduction applicable to all similarly situated executives as set forth in Section 4(a) hereof), (iii)&#160;the relocation of Executive&#8217;s principal place of employment (as provided in Section 3(c) hereof) more than fifty (50) miles from its current location, or (iv)&#160;any other material breach of a provision of this Agreement by the Company (other than a provision that is covered by clause (i), (ii), or (iii) above).  Executive acknowledges and agrees that Executive&#8217;s exclusive remedy in the event of any breach of this Agreement shall be to assert Good Reason pursuant to the terms and conditions of Section 8(e) hereof. Notwithstanding the foregoing, during the Term, in the event that the Board reasonably believes that Executive may have engaged in conduct that could constitute Cause hereunder, the Board may, in its sole and absolute discretion, suspend Executive from performing Executive&#8217;s duties hereunder, and in no event shall any such suspension constitute an event pursuant to which Executive may terminate employment with Good Reason or otherwise constitute a breach hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no such suspension shall alter the Company&#8217;s obligations under this Agreement during such period of suspension.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Interference Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Confidentiality, Non-Interference, and Invention Assignment Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.36pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any individual, corporation, partnership, limited liability company, joint venture, association, jointstock company, trust (charitable or non-charitable), unincorporated organization, or other form of business entity.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Release of Claims in substantially the same form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (as the same may be revised from time to time by the Company upon the advice of counsel).</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 8(g) hereof.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the twelve-month period following Executive&#8217;s termination by the Company without Cause (other than by reason of death or Disability) or by Executive for Good Reason.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the period specified in Section 2 hereof.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Transition Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date on which Executive is appointed as Chief Financial Officer of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Acceptance and Term.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company agrees to employ Executive, and Executive agrees to serve the Company, on the terms and conditions set forth herein.  The Term shall commence on July 1, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and shall continue until terminated in accordance with the provisions of Section 8 hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Position, Duties, and Responsibilities&#59; Place of Performance.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Position, Duties, and Responsibilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Term, from the Commencement Date through the Transition Date, Executive shall be employed and serve as the Executive Vice President, Deputy Chief Financial Officer of the Company, and following the Transition Date, Executive shall be employed as the Executive Vice President, Chief Financial Officer of the Company, in each case, together with such other position or positions consistent with Executive&#8217;s title as the Chief Executive Officer shall specify from time to time, and shall have such duties and responsibilities commensurate with such title.  Executive also agrees to serve as an officer and&#47;or director of any other member of the Company Group, in each case without additional compensation.  As the Executive Vice President, Deputy Chief Financial Officer, Executive shall report to the Chief Financial Officer. As the Executive Vice President, Chief Financial Officer, Executive shall report to the Chief Executive Officer.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall devote Executive&#8217;s full business time, attention, skill, and best efforts to the performance of Executive&#8217;s duties under this Agreement and shall not engage in any other business or occupation during the Term, including, without limitation, any activity that (x)&#160;conflicts with the interests of the Company or any other member of the Company Group, (y)&#160;interferes with the proper and efficient performance of Executive&#8217;s duties for the Company, or (z)&#160;interferes with Executive&#8217;s exercise of judgment in the Company&#8217;s best interests.  Notwithstanding the foregoing, nothing herein shall preclude Executive from (i)&#160;serving, with the prior written consent of the Board, as a member of the boards of directors or advisory boards (or their equivalents in the case of a non-corporate entity) of non-competing businesses and charitable organizations, (ii)&#160;engaging in charitable activities and community affairs, and (iii)&#160;managing Executive&#8217;s personal investments and affairs&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the activities set out in clauses (i), (ii), and (iii) shall be limited by Executive so as not to materially interfere, individually or in the aggregate, with the performance of Executive&#8217;s duties and responsibilities hereunder or create a potential business or fiduciary conflict.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Principal Place of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive&#8217;s principal place of employment shall be in Draper, Utah, although Executive understands and agrees that Executive will be required to travel to other sites and locations as needed for business reasons.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Compensation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Term, Executive shall be entitled to the following compensation&#58;</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  From the Commencement Date through January 31, 2021, Executive shall be paid an annualized Base Salary, payable in accordance with the regular payroll practices of the Company, of not less than $305,000 and following January 31, 2021 of not less than $350,000, in each case, with increases, if any, as may be approved in writing by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Compensation Committee&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the foregoing shall not preclude the Company from reducing Executive&#8217;s Base Salary as part of an across-the-board reduction applicable to all similarly situated executives of the Company.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall be eligible for an annual incentive bonus award determined by the Compensation Committee in respect of each fiscal year during the Term (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The target Annual Bonus for each fiscal year shall be 75% of the Base Salary actually earned by Executive, which Executive will be eligible to earn pursuant to annual bonus programs communicated to Executive from time to time. The Annual Bonus shall be paid to Executive at the same time as annual bonuses are generally payable to other senior executives of the Company, subject to Executive&#8217;s continuous employment through the payment date except as otherwise provided for in this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Equity Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall take all actions necessary to grant Executive any equity award comprised of restricted stock units with a fair market value as of the grant date equal to $550,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) under the Company&#8217;s 2014 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Commencement Award shall cliff vest following the expiration of the performance period ending January 31, 2023 based on the total shareholder return vesting metrics approved by the Compensation Committee on March 31, 2020 for the Company&#8217;s performance awards granted to its executives for Fiscal Year 2021.  The Commencement Award shall be subject to the terms and conditions of the Incentive Plan and the Company&#8217;s standard form of restricted stock unit award agreement applicable thereto. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Employee Benefits.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Term, Executive shall be entitled to participate in health, insurance, retirement, and other benefits provided generally to similarly situated executives of the Company.  Executive shall also be entitled to the same number of holidays, vacation days, and sick days, as well as any other benefits, in each case as are generally allowed to similarly situated executives of the Company in accordance with the Company policy as in effect from time to time.  Nothing contained herein shall be construed to limit the Company&#8217;s ability to amend, suspend, or terminate any employee benefit plan or policy at any time without providing Executive notice, and the right to do so is expressly reserved.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Key-Person Insurance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">At any time during the Term, the Company shall have the right to insure the life of Executive for the sole benefit of the Company, in such amounts, and with such terms, as it may determine.  All premiums payable thereon shall be the obligation of the Company.  Executive shall have no interest in any such policy, but agrees to cooperate with the Company in procuring such insurance by submitting to physical examinations, supplying all information required by the insurance company, and executing all necessary documents, provided that no financial obligation is imposed on Executive by any such documents.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Reimbursement of Business Expenses.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Term, the Company shall pay (or promptly reimburse Executive) for documented, out-of-pocket expenses reasonably incurred by Executive in the course of performing Executive&#8217;s duties and responsibilities hereunder, which are consistent with the Company&#8217;s policies in effect from time to time with respect to business expenses, subject to the Company&#8217;s requirements with respect to reporting of such expenses.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Termination of Employment.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Term shall terminate earlier than as provided in Section 2 hereof upon the earliest to occur of (i)&#160;Executive&#8217;s death, (ii)&#160;a termination by reason of a Disability, (iii)&#160;a termination by the Company with or without Cause, and (iv)&#160;a termination by Executive with or without Good Reason.  Upon any termination of Executive&#8217;s employment for any reason, except as may otherwise be requested by the Company in writing and agreed upon in writing by Executive, Executive shall resign from any and all directorships, committee memberships, and any other positions Executive holds with the Company or any other member of the Company Group.  Notwithstanding anything herein to the contrary, the payment (or commencement of a series of payments) hereunder of any &#8220;nonqualified deferred compensation&#8221; (within the meaning of Section&#160;409A of the Code) upon a termination of employment shall be delayed until such time as Executive has also undergone a &#8220;separation from service&#8221; as defined in Treas. Reg.&#160;1.409A-1(h), at which time such nonqualified deferred compensation (calculated as of the date of Executive&#8217;s termination of employment hereunder) shall be paid (or commence to be paid) to Executive on the schedule set forth in this Section 8 as if Executive had undergone such termination of employment (under the same circumstances) on the date of Executive&#8217;s ultimate &#8220;separation from service.&#8221;</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Termination Due to Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive&#8217;s employment shall terminate automatically upon Executive&#8217;s death.  The Company may terminate Executive&#8217;s employment immediately upon the occurrence of a Disability, such termination to be effective upon Executive&#8217;s receipt of written notice of such termination.  Upon Executive&#8217;s death or in the event that Executive&#8217;s employment is terminated due to Executive&#8217;s Disability, Executive or Executive&#8217;s estate or Executive&#8217;s beneficiaries, as the case may be, shall be entitled to&#58;</font></div><div style="margin-bottom:12pt;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)The Accrued Obligations&#59; </font></div><div style="margin-bottom:12pt;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)Any unpaid Annual Bonus in respect of any completed fiscal year that has ended prior to the date of such termination, if any, which amount shall be paid at such time annual bonuses are paid to other senior executives of the Company, but in no event later than the date that is 2&#189; months following the last day of the fiscal year in which such termination occurred&#59; and</font></div><div style="margin-bottom:12pt;text-indent:54.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)Subject to achievement of the applicable performance objectives for the fiscal year of the Company in which Executive&#8217;s termination occurs, as determined by the Compensation Committee, payment of the Annual Bonus that would otherwise have been earned in respect of the fiscal year in which such termination occurred, pro-rated to reflect the number of days Executive was employed during such fiscal year, such amount to be paid at the same time it would otherwise be paid to Executive had no termination occurred, but in no event later </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">than the date that is 2&#189; months following the last day of the fiscal year of the Company in which such termination occurred.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Following Executive&#8217;s death or a termination of Executive&#8217;s employment by reason of a Disability, except as set forth in this Section 8(b), Executive shall have no further rights to any compensation or any other benefits under this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Termination by the Company with Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)The Company may terminate Executive&#8217;s employment at any time with Cause, effective upon Executive&#8217;s receipt of written notice of such termination, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that, to be effective, such written notice must be provided to Executive within sixty (60) days of the Board having actual knowledge of the occurrence of such event and further provided that, with respect to any Cause termination relying on clauses (ii), (vi), or (vii) of the definition of Cause set forth in Section 1(f) hereof, to the extent that such act or acts or failure or failures to act are curable, the Board shall provide Executive with written notice of the Company&#8217;s intention to terminate Executive with Cause, such notice to state in detail the particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination with Cause is based and to provide Executive with ten (10) days to cure the particular act or acts or failure or failures to act (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cure Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and such termination shall be effective at the expiration of the Cure Period unless Executive has fully cured such act or acts or failure or failures to act that give rise to Cause during such Cure Period.</font></div><div style="margin-bottom:12pt;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)In the event that the Company terminates Executive&#8217;s employment with Cause, Executive shall be entitled only to the Accrued Obligations.  Following such termination of Executive&#8217;s employment with Cause, except as set forth in this Section 8(c)(ii), Executive shall have no further rights to any compensation or any other benefits under this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Termination by the Company without Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company may terminate Executive&#8217;s employment at any time without Cause, effective upon Executive&#8217;s receipt of written notice of such termination.  Subject to Section&#160;8(h) below, in the event that Executive&#8217;s employment is terminated by the Company without Cause (other than due to death or Disability), Executive shall be entitled to&#58;</font></div><div style="margin-bottom:12pt;text-indent:60.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)The Accrued Obligations&#59;</font></div><div style="margin-bottom:12pt;text-indent:57.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)Any unpaid Annual Bonus in respect of any completed fiscal year that has ended prior to the date of such termination, which amount shall be paid at such time annual bonuses are paid to other senior executives of the Company, but in no event later than the date that is 2&#189; months following the last day of the fiscal year in which such termination occurred&#59; </font></div><div style="margin-bottom:12pt;text-indent:54.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)Subject to achievement of the applicable performance objectives for the fiscal year of the Company in which Executive&#8217;s termination occurs, as determined by the Compensation Committee, payment of the Annual Bonus that would otherwise have been earned in respect of the fiscal year in which such termination occurred, pro-rated to reflect the number of days Executive was employed during such fiscal year, such amount to be paid at the same </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">time it would otherwise be paid to Executive had no termination occurred, but in no event later than the date that is 2&#189; months following the last day of the fiscal year of the Company in which such termination occurred&#59; </font></div><div style="margin-bottom:12pt;text-indent:54.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)Continued payment of Base Salary during the Severance Term, payable in accordance with the Company&#8217;s regular payroll practices&#59; and</font></div><div style="margin-bottom:12pt;text-indent:58.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)To the extent permitted by applicable law without any penalty to Executive or any member of the Company Group and subject to Executive&#8217;s election of COBRA continuation coverage under the Company&#8217;s group health plan, on the first regularly scheduled payroll date of each month of the Severance Term, the Company will pay Executive an amount equal to the &#8220;applicable percentage&#8221; of the monthly COBRA premium cost&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the payments pursuant to this clause (vi) shall cease earlier than the expiration of the Severance Term in the event that Executive becomes eligible to receive any health benefits, including through a spouse&#8217;s employer, during the Severance Term.  For purposes hereof, the &#8220;applicable percentage&#8221; shall be the percentage of Executive&#8217;s health care premium costs covered by the Company as of the date of termination.  Amounts paid by the Company will be taxable to the extent required to avoid adverse consequences to Executive or the Company under either Section 105(h) of the Code or the Patient Protection and Affordable Care Act of 2010.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the payments and benefits described in clauses (ii), (iii), (iv), and (v) above shall immediately terminate, and the Company shall have no further obligations to Executive with respect thereto, in the event that Executive breaches any provision of the Non-Interference Agreement.  Following such termination of Executive&#8217;s employment by the Company without Cause, except as set forth in this Section 8(d), Executive shall have no further rights to any compensation or any other benefits under this Agreement.  For the avoidance of doubt, subject to Section&#160;8(h) below, Executive&#8217;s sole and exclusive remedy upon a termination of employment by the Company without Cause shall be receipt of the Severance Benefits.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Termination by Executive with Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive may terminate Executive&#8217;s employment with Good Reason by providing the Company written notice setting forth in reasonable specificity the event that constitutes Good Reason, which written notice, to be effective, must be provided to the Company within sixty (60) days of the occurrence of such event.  Said notice shall state in detail the particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination for Good Reason is based and shall provide the Company with a Cure Period (as defined in Section 8(c)(i) above), and such termination shall be effective at the expiration of the Cure Period unless the Company has fully cured such act or acts or failure or failures to act that give rise to Good Reason during such Cure Period. In the event of termination with Good Reason, subject to Section&#160;8(h) below, Executive shall be entitled to the same payments and benefits as provided in Section 8(d) hereof for a termination by the Company without Cause, subject to the same conditions on payment and benefits as described in Section 8(d) hereof.  Following such termination of Executive&#8217;s employment by Executive with Good Reason, except as set forth in this Section 8(e), Executive shall have no further rights to any compensation or any other benefits under this Agreement.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the avoidance of doubt, subject to Section&#160;8(h) below, Executive&#8217;s sole and exclusive remedy upon a termination of employment with Good Reason shall be receipt of the Severance Benefits.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Termination by Executive without Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive may terminate Executive&#8217;s employment without Good Reason by providing the Company thirty (30) days&#8217; written notice of such termination.  In the event of a termination of employment by Executive under this Section 8(f), Executive shall be entitled only to the Accrued Obligations.  In the event of termination of Executive&#8217;s employment under this Section 8(f), the Company may, in its sole and absolute discretion, by written notice accelerate such date of termination without changing the characterization of such termination as a termination by Executive without Good Reason.  Following such termination of Executive&#8217;s employment by Executive without Good Reason, except as set forth in this Section 8(f), Executive shall have no further rights to any compensation or any other benefits under this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision herein to the contrary, the payment of any amount or provision of any benefit pursuant to subsection (b), (d), or (e) of this Section 8 (other than the Accrued Obligations) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be conditioned upon Executive&#8217;s execution, delivery to the Company, and non-revocation of the Release of Claims (and the expiration of any revocation period contained in such Release of Claims) within sixty (60) days following the date of Executive&#8217;s termination of employment hereunder.  If Executive fails to execute the Release of Claims in such a timely manner so as to permit any revocation period to expire prior to the end of such sixty (60) day period, or timely revokes Executive&#8217;s acceptance of such release following its execution, Executive shall not be entitled to any of the Severance Benefits.  Further, (i)&#160;to the extent that any of the Severance Benefits constitutes &#8220;nonqualified deferred compensation&#8221; for purposes of Section&#160;409A of the Code, any payment of any amount or provision of any benefit otherwise scheduled to occur prior to the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day following the date of Executive&#8217;s termination of employment hereunder, but for the condition on executing the Release of Claims as set forth herein, shall not be made until the first regularly scheduled payroll date following such sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day and (ii)&#160;to the extent that any of the Severance Benefits do not constitute &#8220;nonqualified deferred compensation&#8221; for purposes of Section&#160;409A of the Code, any payment of any amount or provision of any benefit otherwise scheduled to occur following the date of Executive&#8217;s termination of employment hereunder, but for the condition on executing the Release of Claims as set forth herein, shall not be made until the first regularly scheduled payroll date following the date the Release of Claims is timely executed and the applicable revocation period has ended, after which, in each case, any remaining Severance Benefits shall thereafter be provided to Executive according to the applicable schedule set forth herein.  For the avoidance of doubt, in the event of a termination due to Executive&#8217;s death or Disability, Executive&#8217;s obligations herein to execute and not revoke the Release of Claims may be satisfied on Executive&#8217;s behalf by Executive&#8217;s estate or a person having legal power of attorney over Executive&#8217;s affairs.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Termination Upon a Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision herein to the contrary, if Executive experiences a &#8220;Termination Upon a Change in Control,&#8221; as defined in the Executive Severance Plan, Executive shall be eligible to receive such payments and benefits </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as provided for in the Executive Severance Plan, subject to the terms and conditions set forth therein, in lieu of any Severance Benefits he may be eligible to receive pursuant to subsection (d) or (e) of this Section 8.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Non-Interference Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As a condition of, and prior to commencement of, Executive&#8217;s employment with the Company, Executive shall have executed and delivered to the Company the Non-Interference Agreement.  The parties hereto acknowledge and agree that this Agreement and the Non-Interference Agreement shall be considered separate contracts, and the Non-Interference Agreement will survive the termination of this Agreement for any reason.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Representations and Warranties of Executive.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive represents and warrants to the Company that&#8212;</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">Executive is entering into this Agreement voluntarily and that Executive&#8217;s employment hereunder and compliance with the terms and conditions hereof will not conflict with or result in the breach by Executive of any agreement to which Executive is a party or by which Executive may be bound&#59;</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Executive has not violated, and in connection with Executive&#8217;s employment with the Company will not violate, any non-solicitation, non-competition, or other similar covenant or agreement of a prior employer by which Executive is or may be bound&#59; and</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">in connection with Executive&#8217;s employment with the Company, Executive has not used and will not use any confidential or proprietary information Executive may have obtained in connection with employment with any prior employer.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Taxes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company may withhold from any payments made under this Agreement all applicable taxes, including, but not limited to, income, employment, and social insurance taxes, as shall be required by law.  Executive acknowledges and represents that the Company has not provided any tax advice to Executive in connection with this Agreement and that Executive has been advised by the Company to seek tax advice from Executive&#8217;s own tax advisors regarding this Agreement and payments that may be made to Executive pursuant to this Agreement, including specifically, the application of the provisions of Section&#160;409A of the Code to such payments.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Set Off&#59; Mitigation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s obligation to pay Executive the amounts provided and to make the arrangements provided hereunder shall be subject to set-off, counterclaim, and recoupment of amounts owed by Executive to any member of the Company Group&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, however, that (i) prior to exercising any right of set-off, counterclaim, or recoupment, the Company shall provide Executive with written notice setting forth, in detail, the facts on which it relies to support its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">claim of set-off, counterclaim, or recoupment&#59; (ii) to the extent any amount so subject to set-off, counterclaim, or recoupment is payable in installments hereunder, such set-off, counterclaim, or recoupment shall not modify the applicable payment date of any installment&#59; and (iii) to the extent an obligation cannot be satisfied by reduction of a single installment payment, any portion not satisfied shall remain an outstanding obligation of Executive and shall be applied to the next installment only at such time the installment is otherwise payable pursuant to the specified payment schedule.  Executive shall not be required to mitigate the amount of any payment or benefit provided pursuant to this Agreement by seeking other employment or otherwise, and except as provided in Section 8(d)(v) hereof, the amount of any payment or benefit provided for pursuant to this Agreement shall not be reduced by any compensation earned as a result of Executive&#8217;s other employment or otherwise.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Additional Section&#160;409A Provisions.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding any provision in this Agreement to the contrary&#8212;</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">Any payment otherwise required to be made hereunder to Executive at any date as a result of the termination of Executive&#8217;s employment shall be delayed for such period of time as may be necessary to meet the requirements of Section&#160;409A(a)(2)(B)(i) of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Delay Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  On the first business day following the expiration of the Delay Period, Executive shall be paid, in a single cash lump sum, an amount equal to the aggregate amount of all payments delayed pursuant to the preceding sentence, and any remaining payments not so delayed shall continue to be paid pursuant to the payment schedule set forth herein.  </font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Each payment in a series of payments hereunder shall be deemed to be a separate payment for purposes of Section&#160;409A of the Code.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">To the extent that any right to reimbursement of expenses or payment of any benefit in-kind under this Agreement constitutes nonqualified deferred compensation (within the meaning of Section&#160;409A of the Code), (i)&#160;any such expense reimbursement shall be made by the Company no later than the last day of the taxable year following the taxable year in which such expense was incurred by Executive, (ii)&#160;the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (iii)&#160;the amount of expenses eligible for reimbursement or in-kind benefits provided during any taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other taxable year&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that the foregoing clause (iii) shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">While the payments and benefits provided hereunder are intended to be structured in a manner to avoid the implication of any penalty taxes under Section&#160;409A of the Code, in no event whatsoever shall the Company or any of its affiliates (including, without limitation, the Company) be liable for any additional tax, interest, or penalties that may be imposed on Executive as a result of Section&#160;409A of the Code or any damages for failing to comply with Section&#160;409A of the Code (other than for withholding obligations or other obligations applicable to employers, if any, under Section&#160;409A of the Code).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Golden Parachute Tax Provision. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If there is a change in ownership or control of the Company that would cause any payment or distribution by the Company or any other Person or entity to Executive or for Executive&#8217;s benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to be subject to the excise tax imposed by Section&#160;4999 of the Code (such excise tax, together with any interest or penalties incurred by Executive with respect to such excise tax, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then Executive will receive the greatest of the following, whichever gives Executive the highest net after-tax amount (after taking into account federal, state, local and social security taxes)&#58; (a) the Payments or (b) one dollar less than the amount of the Payments that would subject Executive to the Excise Tax (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Safe Harbor Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).&#160; If a reduction in the Payments is necessary so that the Payments equal the Safe Harbor Amount and none of the Payments constitutes nonqualified deferred compensation (within the meaning of Section 409A of the Code), then the reduction shall occur in the manner Executive elects in writing prior to the date of payment.&#160; If any Payment constitutes nonqualified deferred compensation or if Executive fails to elect an order, then the Payments to be reduced will be determined in a manner which has the least economic cost to Executive and, to the extent the economic cost is equivalent, will be reduced in the inverse order of when payment would have been made to Executive, until the reduction is achieved.&#160; All determinations required to be made under this Section 14, including whether and when the Safe Harbor Amount is required and the amount of the reduction of the Payments and the assumptions to be utilized in arriving at such determination, shall be made by a certified public accounting firm designated by the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).&#160; All fees and expenses of the Accounting Firm shall be borne solely by the Company.&#160; Any determination by the Accounting Firm shall be binding upon Company and Executive.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Clawback.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments made pursuant to this Agreement are subject to the &#8220;clawback&#8221; obligations of Section&#160;954 of the Dodd-Frank Wall Street Reform and Consumer Act, as may be amended from time to time, any other &#8220;clawback&#8221; obligations pursuant to applicable law, rules, and regulations, the HealthEquity, Inc. Clawback Policy and any other clawback policy that may be adopted by the Company from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Indemnification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive shall be indemnified and held harmless pursuant to the terms and conditions set forth in that certain Indemnification Agreement, dated June 25, 2020, by and between Executive and the Company, as may be amended from time to time (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Successors and Assigns&#59; No Third-Party Beneficiaries.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">The Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall inure to the benefit of the Company and its respective successors and assigns.  Neither this Agreement nor any of the rights, obligations, or interests arising hereunder may be assigned by the Company to a Person (other than another </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">member of the Company Group, or its or their respective successors) without Executive&#8217;s prior written consent (which shall not be unreasonably withheld, delayed, or conditioned)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, however, that in the event of a sale of all or substantially all of the assets of the Company or any direct or indirect division or subsidiary thereof to which Executive&#8217;s employment primarily relates, the Company may provide that this Agreement will be assigned to, and assumed by, the acquiror of such assets, it being agreed that in such circumstances, Executive&#8217;s consent will not be required in connection therewith.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive&#8217;s rights and obligations under this Agreement shall not be transferable by Executive by assignment or otherwise, without the prior written consent of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if Executive shall die, all amounts then payable to Executive hereunder shall be paid in accordance with the terms of this Agreement to Executive&#8217;s devisee, legatee, or other designee, or if there be no such designee, to Executive&#8217;s estate.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as otherwise set forth in Section 8(b) or Section 17(b) hereof, nothing expressed or referred to in this Agreement will be construed to give any Person other than the Company, the other members of the Company Group, and Executive any legal or equitable right, remedy, or claim under or with respect to this Agreement or any provision of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Waiver and Amendments.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any waiver, alteration, amendment, or modification of any of the terms of this Agreement shall be valid only if made in writing and signed by each of the parties hereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any such waiver, alteration, amendment, or modification must be consented to on the Company&#8217;s behalf by the Board.  No waiver by either of the parties hereto of their rights hereunder shall be deemed to constitute a waiver with respect to any subsequent occurrences or transactions hereunder unless such waiver specifically states that it is to be construed as a continuing waiver.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Severability.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any covenants or such other provisions of this Agreement are found to be invalid or unenforceable by a final determination of a court of competent jurisdiction, (a)&#160;the remaining terms and provisions hereof shall be unimpaired, and (b)&#160;the invalid or unenforceable term or provision hereof shall be deemed replaced by a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision hereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Governing Law and Jurisdiction.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXCEPT WHERE PREEMPTED BY FEDERAL LAW, THE VALIDITY, INTERPRETATION, CONSTRUCTION, AND PERFORMANCE OF THIS AGREEMENT IS GOVERNED BY AND IS TO BE CONSTRUED UNDER THE LAWS OF THE STATE OF UTAH APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT STATE, WITHOUT REGARD TO CONFLICT OF LAWS RULES.  ANY DISPUTE OR </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR CLAIM OF BREACH HEREOF SHALL BE BROUGHT EXCLUSIVELY IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH, TO THE EXTENT FEDERAL JURISDICTION EXISTS, AND IN STATE COURT SITTING IN SALT LAKE CITY, UTAH, BUT ONLY IN THE EVENT FEDERAL JURISDICTION DOES NOT EXIST, AND ANY APPLICABLE APPELLATE COURTS.  BY EXECUTION OF THIS AGREEMENT, THE PARTIES HERETO, AND THEIR RESPECTIVE AFFILIATES, CONSENT TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS, AND WAIVE ANY RIGHT TO CHALLENGE JURISDICTION OR VENUE IN SUCH COURT WITH REGARD TO ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS AGREEMENT.  EACH PARTY TO THIS AGREEMENT ALSO HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS AGREEMENT.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Notices.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Place of Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom or which it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that unless and until some other address be so designated, all notices and communications by Executive to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices and communications by the Company to Executive may be given to Executive personally or may be mailed to Executive at Executive&#8217;s last known address, as reflected in the Company&#8217;s records.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Date of Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any notice so addressed shall be deemed to be given or received (i)&#160;if delivered by hand, on the date of such delivery, (ii)&#160;if mailed by courier or by overnight mail, on the first business day following the date of such mailing, and (iii)&#160;if mailed by registered or certified mail, on the third business day after the date of such mailing.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Section Headings.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to constitute a part thereof or affect the meaning or interpretation of this Agreement or of any term or provision hereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Entire Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement, together with any documents referenced within this Agreement and any exhibits attached hereto, the Executive Severance Plan, the HealthEquity, Inc. Clawback Policy and Executive&#8217;s Indemnification Agreement, constitutes the entire understanding and agreement of the parties hereto regarding the employment of Executive during the Term of this Agreement.  As a condition to Executive&#8217;s continued employment by the Company, Executive shall deliver an executed copy of the Non-Interference Agreement contemporaneously with the execution of this Agreement. This Agreement supersedes all prior negotiations, discussions, correspondence, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">communications, understandings, and agreements between the parties relating to the subject matter of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Survival of Operative Sections.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon any termination of Executive&#8217;s employment, the provisions of Section 8 through 25 of this Agreement (together with any related definitions set forth in Section 1 hereof) shall survive to the extent necessary to give effect to the provisions thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">Counterparts.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.  The execution of this Agreement may be by actual signature or by signature delivered by facsimile or by e-mail as a portable document format (.pdf) file or image file attachment.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signatures to appear on the following page(s).&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><div id="i0f76bd84b6c44083a8681975deb767aa_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.</font></div><div style="margin-bottom:30pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HEALTHEQUITY, INC.</font></div><div style="margin-bottom:30pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Jon Kessler</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________</font></div><div style="margin-bottom:0.12pt;padding-left:2.16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;  Jon Kessler </font></div><div style="margin-bottom:0.12pt;padding-left:2.16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; President and CEO</font></div><div style="margin-bottom:30pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE</font></div><div style="margin-bottom:30pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Tyson Murdock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">___________</font></div><div style="margin-bottom:0.12pt;padding-left:2.16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tyson Murdock</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="i0f76bd84b6c44083a8681975deb767aa_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONFIDENTIALITY, NON-INTERFERENCE, AND INVENTION ASSIGNMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As a condition of my continuing employment with, HealthEquity, Inc., a Delaware corporation with its principal place of business in Draper, Utah (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by the Company, I agree to the following terms set forth in this Confidentiality, Non-Interference, and Invention Assignment Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Interference Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:25.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Group Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I acknowledge that, during the course of my employment, I will have access to information about the Company and its direct and indirect subsidiaries and affiliates (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and that my employment with the Company shall bring me into close contact with confidential and proprietary information of any member of the Company Group.  In recognition of the foregoing, I agree, at all times during the term of my employment with the Company and thereafter, to hold in confidence, and not to use, except for the benefit of any member of the Company Group, or to disclose to any person, firm, corporation, or other entity without written authorization of the Company, any Confidential Information that I obtain or create.  I further agree not to make copies of such Confidential Information except as authorized by the Company.  I understand that &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means information that any member of the Company Group has developed, acquired, created, compiled, discovered, or owned or will develop, acquire, create, compile, discover, or own, that has value in or to the business of any member of the Company Group that is not generally known and that the Company wishes to maintain as confidential.  I understand that Confidential Information includes, but is not limited to, any and all non-public information that relates to the actual or anticipated business and&#47;or products, research, or development of the Company, or to the Company&#8217;s technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company&#8217;s products or services and markets, customer lists, and customers (including, but not limited to, customers of the Company on whom I called or with whom I may become acquainted during the term of my employment), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, employee salary and compensation information, sales incentive plans, and other business information disclosed by the Company either directly or indirectly in writing, orally, or by drawings or inspection of premises, parts, equipment, or other Company property.  Notwithstanding the foregoing, Confidential Information shall not include (i)&#160;any of the foregoing items that have become publicly and widely known through no unauthorized disclosure by me or others who were under confidentiality obligations as to the item or items involved, or (ii)&#160;any information that I am required to disclose to, or by, any governmental or judicial authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in such event I will give the Company prompt written notice thereof so that any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">member of the Company Group may seek an appropriate protective order and&#47;or waive in writing compliance with the confidentiality provisions of this Non-Interference Agreement.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:21.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Former Employer Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I represent that my performance of all of the terms of this Non-Interference Agreement as an employee of the Company has not breached and will not breach any agreement to keep in confidence proprietary information, knowledge, or data acquired by me in confidence or trust prior or subsequent to the commencement of my employment with the Company, and I will not disclose to any member of the Company Group, or induce any member of the Company Group to use, any developments, or confidential or proprietary information or material I may have obtained in connection with employment with any prior employer in violation of a confidentiality agreement, nondisclosure agreement, or similar agreement with such prior employer.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:18.51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Third Party Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I understand that the Company Group has received and in the future may receive from third parties confidential or proprietary information (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Third Party Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) subject to a duty on the Company Group&#8217;s part to maintain the confidentiality of such information and to use it only for certain limited purposes.  In recognition of the foregoing, I agree, at all times during the period of my employment with the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and thereafter, to hold in confidence and will not disclose to anyone (other than Company Group personnel who need to know such information in connection with their work for the Company Group), and not to use, except for the benefit of the Company Group, Third Party Information without the express prior written consent of an officer of the Company and otherwise treat Third Party Information as Confidential Information.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-align:justify;text-indent:19.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Whistleblower&#59; Defend Trade Secrets Act Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">In addition, I understand that nothing in this Agreement shall be construed to prohibit me from reporting possible violations of law or regulation to any governmental agency or regulatory body or making other disclosures that are protected under any law or regulation, or from filing a charge with or participating in any investigation or proceeding conducted by any governmental agency or regulatory body.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">I understand that the Defend Trade Secrets Act provides that I may not be held criminally or civilly liable under any Federal or state trade secret law for the disclosure of a trade secret that is made in confidence to a Federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; or that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In the event that I file a lawsuit for retaliation by any member of the Company Group for reporting a suspected violation of law, I may disclose the trade secret to my attorney and use the trade secret information in the court proceeding, if I file any document containing the trade secret under seal and do not disclose the trade secret, except pursuant to court order.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Developments Retained and Licensed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I have attached hereto, as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a list describing with particularity all developments, original works of authorship, improvements, and trade secrets that I can demonstrate were created or owned by me prior to the commencement of my employment (collectively referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which belong solely to me or belong to me jointly with another, that relate in any way to any of the actual or proposed businesses, products, or research and development of any member of the Company Group, and that are not assigned to the Company hereunder, or if no such list is attached, I represent that there are no such Prior Developments.  If, during any period during which I perform or performed services for any member of the Company Group both before or after the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), whether as an officer, employee, director, independent contractor, consultant, or agent, or in any other capacity, I incorporate (or have incorporated) into any member of the Company Group&#8217;s product or process a Prior Development owned by me or in which I have an interest, I hereby grant each member of the Company Group, and each member of the Company Group shall have, a non-exclusive, royalty-free, irrevocable, perpetual, transferable worldwide license (with the right to sublicense) to make, have made, copy, modify, make derivative works of, use, sell, and otherwise distribute such Prior Development as part of or in connection with such product or process.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:19.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment of Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I agree that I will, without additional compensation, promptly make full written disclosure to the Company, and will hold in trust for the sole right and benefit of the Company all developments, original works of authorship, inventions, concepts, know-how, improvements, trade secrets, and similar proprietary rights, whether or not patentable or registrable under copyright or similar laws, which I may solely or jointly conceive or develop or reduce to practice, or have solely or jointly conceived or developed or reduced to practice, or have caused or may cause to be conceived or developed or reduced to practice, during the Assignment Period, whether or not during regular working hours, provided they either (i)&#160;relate at the time of conception, development or reduction to practice to the business of any member of the Company Group, or the actual or anticipated research or development of any member of the Company Group&#59; (ii)&#160;result from or relate to any work performed for any member of the Company Group&#59; or (iii)&#160;are developed through the use of equipment, supplies, or facilities of any member of the Company Group, or any Confidential Information, or in consultation with personnel of any member of the Company Group (collectively referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  I further acknowledge that all Developments made by me (solely or jointly with others) within the scope of and during the Assignment Period are &#8220;works made for hire&#8221; (to the greatest extent permitted by applicable law) for which I am, in part, compensated by my salary, unless regulated otherwise by law, but that, in the event any such Development is deemed not to be a work made for hire, I hereby assign to the Company, or its designee, all my right, title, and interest throughout the world in and to any such Development.  If any Developments cannot be assigned, I hereby grant to each member of the Company Group an exclusive, assignable, irrevocable, perpetual, worldwide, sublicenseable (through one or multiple tiers), royalty-free, unlimited license to use, make, modify, sell, offer for sale, reproduce, distribute, create derivative works of, publicly perform, publicly display and digitally perform and display such work in any media now known or hereafter known.  Outside the scope of my service, whether during or after my employment with any member of the Company Group, I agree not to (i)&#160;modify, adapt, alter, translate, or create derivative works from any such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">work of authorship or (ii)&#160;merge any such work of authorship with other Developments.  To the extent rights related to paternity, integrity, disclosure and withdrawal (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Moral Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) may not be assignable under applicable law and to the extent the following is allowed by the laws in the various countries where Moral Rights exist, I hereby irrevocably waive such Moral Rights and consent to any action of any member of the Company Group that would violate such Moral Rights in the absence of such consent.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Maintenance of Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I agree to keep and maintain adequate and current written records of all Developments made by me (solely or jointly with others) during the Assignment Period. The records may be in the form of notes, sketches, drawings, flow charts, electronic data or recordings, and any other format.  The records will be available to and remain the sole property of any member of the Company Group at all times.  I agree not to remove such records from the Company&#8217;s place of business except as expressly permitted by Company Group policy, which may, from time to time, be revised at the sole election of such member of the Company Group for the purpose of furthering the business of such member of the Company Group.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:12.51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I agree to assist the Company, or its designee, at the Company&#8217;s expense, in every way to secure the rights of each member of the Company Group in the Developments and any copyrights, patents, trademarks, service marks, database rights, domain names, mask work rights, moral rights, and other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments, recordations, and all other instruments that the Company shall deem necessary in order to apply for, obtain, maintain, and transfer such rights and in order to assign and convey to each member of the Company Group the sole and exclusive right, title, and interest in and to such Developments, and any intellectual property and other proprietary rights relating thereto.  I further agree that my obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after the Assignment Period until the expiration of the last such intellectual property right to expire in any country of the world&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company shall reimburse me for my reasonable expenses incurred in connection with carrying out the foregoing obligation.  If the Company is unable because of my mental or physical incapacity or unavailability for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Developments or original works of authorship assigned to the Company as above, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact to act for and in my behalf and stead to execute and file any such applications or records and to do all other lawfully permitted acts to further the application for, prosecution, issuance, maintenance, and transfer of letters patent or registrations thereon with the same legal force and effect as if originally executed by me.  I hereby waive and irrevocably quitclaim to the Company any and all claims, of any nature whatsoever, that I now or hereafter have for past, present, or future infringement of any and all proprietary rights assigned to the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Returning Company Group Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I agree that, at the time of termination of my employment with the Company for any reason, I will deliver to the Company (and will not keep in my possession, recreate, or deliver to anyone else) any and all Confidential Information and all other documents, materials, information, and property developed by me pursuant to my employment or otherwise belonging to the Company. I agree further that any property situated on the Company&#8217;s premises and owned by the Company (or any other member of the Company Group), including disks and other storage media, filing cabinets, and other work areas, is subject to inspection by personnel of any member of the Company Group at any time with or without notice.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Disclosure of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As long as it remains in effect, I will disclose the existence of this Non-Interference Agreement to any prospective employer, partner, co-venturer, investor, or lender prior to entering into an employment, partnership, or other business relationship with such person or entity.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Restrictions on Interfering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:19.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Employment Period and the Post-Termination Non-Compete Period, I shall not, directly or indirectly, individually or on behalf of any person, company, enterprise, or entity, or as a sole proprietor, partner, stockholder, director, officer, principal, agent, or executive, or in any other capacity or relationship, engage in any Competitive Activities or own any securities (debt or equity) in any person, company, enterprise, or entity that is engaged in Competitive Activities, within the United States or any other jurisdiction in which the Company Group is actively engaged in business.  Notwithstanding the foregoing, my ownership of securities of a public company engaged in Competitive Activities not in excess of three percent (3%) of any class of such securities shall not be considered a breach of the covenants set forth in this Section.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Interference</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the Employment Period and the Post-Termination Non-Interference Period, I shall not, directly or indirectly for my own account or for the account of any other individual or entity, engage in Interfering Activities.  </font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:19.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Non-Interference Agreement&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Business Relation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any current or prospective client, customer, licensee, or other business relation of any member of the Company Group, or any such relation that was a client, customer, licensee, supplier, or other business relation within the six (6) month period prior to the expiration of the Employment Period, in each case, to whom I provided services, or with whom I transacted business, or whose identity became known to me in connection with my relationship with or employment by the Company Group.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Competitive Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean consumer health care related businesses, including the business of acting as custodian or administrator for medical payment reimbursement accounts and other consumer-directed benefits, including, but not limited to, health savings accounts, flexible spending accounts and health reimbursement accounts, COBRA </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">administration, commuter and other benefits, or any business activities in which any member of the Company Group is engaged (or has committed plans to engage) during the Employment Period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Interfering Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (A)&#160;encouraging, soliciting, or inducing, or in any manner attempting to encourage, solicit, or induce, any Person employed by, or providing consulting services to, any member of the Company Group to terminate such Person&#8217;s employment or services (or in the case of a consultant, materially reducing such services) with any member of the Company Group&#59; (B)&#160;hiring any individual who was employed by any member of the Company Group within the six (6) month period prior to the date of such hiring&#59; or (C)&#160;encouraging, soliciting, or inducing, or in any manner attempting to encourage, solicit, or induce, any Business Relation to cease doing business with or reduce the amount of business conducted with any member of the Company Group, or in any way interfering with the relationship between any such Business Relation and any member of the Company Group.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any individual, corporation, partnership, limited liability company, joint venture, association, jointstock company, trust (charitable or non-charitable), unincorporated organization, or other form of business entity.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Post-Termination Non-Compete Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the period commencing on the date of the termination of the Employment Period for any reason and ending on the twelve (12) month anniversary of such date of termination.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Post-Termination Non-Interference Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the period commencing on the date of the termination of the Employment Period for any reason and ending on the twenty-four (24) month anniversary of such date of termination.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I agree that during the Employment Period, and at all times thereafter, I will not make any disparaging or defamatory comments regarding any member of the Company Group or its respective current or former directors, officers, employees or shareholders in any respect or make any comments concerning any aspect of my relationship with any member of the Company Group or any conduct or events which precipitated any termination of my employment from any member of the Company Group.  However, my obligations under this subparagraph (d) shall not apply to disclosures required by applicable law, regulation, or order of a court or governmental agency.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Reasonableness of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I acknowledge and recognize the highly competitive nature of the Company&#8217;s business, that access to Confidential Information renders me special and unique within the Company&#8217;s industry, and that I will have the opportunity to develop substantial relationships with existing and prospective clients, accounts, customers, consultants, contractors, investors, and strategic partners of any member of the Company Group during the course of and as a result of my employment with the Company.  In light of the foregoing, I recognize and acknowledge that the restrictions and limitations set forth in this Non-Interference Agreement are reasonable and valid in geographical and temporal scope and in all other respects and are essential to protect the value </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of the business and assets of any member of the Company Group.  I acknowledge further that the restrictions and limitations set forth in this Non-Interference Agreement  will not materially interfere with my ability to earn a living following the termination of my employment with the Company and that my ability to earn a livelihood without violating such restrictions is a material condition to my employment with the Company. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Independence&#59; Severability&#59; Blue Pencil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each of the rights enumerated in this Non-Interference Agreement shall be independent of the others and shall be in addition to and not in lieu of any other rights and remedies available to any member of the Company Group at law or in equity.  If any of the provisions of this Non-Interference Agreement or any part of any of them is hereafter construed or adjudicated to be invalid or unenforceable, the same shall not affect the remainder of this Non-Interference Agreement, which shall be given full effect without regard to the invalid portions.  If any of the covenants contained herein are held to be invalid or unenforceable because of the duration of such provisions or the area or scope covered thereby, I agree that the court making such determination shall have the power to reduce the duration, scope, and&#47;or area of such provision to the maximum and&#47;or broadest duration, scope, and&#47;or area permissible by law, and in its reduced form said provision shall then be enforceable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I expressly acknowledge that any breach or threatened breach of any of the terms and&#47;or conditions set forth in this Non-Interference Agreement may result in substantial, continuing, and irreparable injury to the members of the Company Group.  Therefore, I hereby agree that, in addition to any other remedy that may be available to the Company, any member of the Company Group shall be entitled to injunctive relief, specific performance, or other equitable relief by a court of appropriate jurisdiction in the event of any breach or threatened breach of the terms of this Non-Interference Agreement without the necessity of proving irreparable harm or injury as a result of such breach or threatened breach.  Notwithstanding any other provision to the contrary, I acknowledge and agree that the Post-Termination Non-Compete Period, or Post-Termination Non-Interference Period, as applicable, shall be tolled during any period of violation of any of the covenants in Section 5 hereof and during any other period required for litigation during which the Company or any other member of the Company Group seeks to enforce such covenants against me if it is ultimately determined that I was in breach of such covenants.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I agree that, following any termination of my employment, I will continue to provide reasonable cooperation to the Company and&#47;or any other member of the Company Group and its or their respective counsel in connection with any investigation, administrative proceeding, or litigation relating to any matter that occurred during my employment in which I was involved or of which I have knowledge.  As a condition of such cooperation, the Company shall reimburse me for reasonable out-of-pocket expenses incurred at the request of the Company with respect to my compliance with this paragraph.  I also agree that, in the event that I am subpoenaed by any person or entity (including, but not limited to, any government agency) to give testimony or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provide documents (in a deposition, court proceeding, or otherwise) that in any way relates to my employment by the Company and&#47;or any other member of the Company Group, I will give prompt notice of such request to the Company and will make no disclosure until the Company and&#47;or the other member of the Company Group has had a reasonable opportunity to contest the right of the requesting person or entity to such disclosure.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.7pt">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:12.51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">xiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law, Venue and Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  EXCEPT WHERE PREEMPTED BY FEDERAL LAW, THE VALIDITY, INTERPRETATION, CONSTRUCTION, AND PERFORMANCE OF THIS NON-INTERFERENCE AGREEMENT IS GOVERNED BY AND IS TO BE CONSTRUED UNDER THE LAWS OF THE STATE OF UTAH APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT STATE, WITHOUT REGARD TO CONFLICT OF LAWS RULES.  ANY DISPUTE OR CLAIM ARISING OUT OF OR RELATING TO THIS RELEASE OR CLAIM OF BREACH HEREOF SHALL BE BROUGHT EXCLUSIVELY IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH, TO THE EXTENT FEDERAL JURISDICTION EXISTS, OR IN STATE DISTRICT COURT SITTING IN SALT LAKE CITY, UTAH, BUT ONLY IN THE EVENT FEDERAL JURISDICTION DOES NOT EXIST, AND ANY APPLICABLE APPELLATE COURTS.  FURTHER, I HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS NON-INTERFERENCE AGREEMENT.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:13.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">xiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Non-Interference Agreement sets forth the entire agreement and understanding between the Company and me relating to the subject matter herein and merges all prior discussions between us.  No modification or amendment to this Non-Interference Agreement, nor any waiver of any rights under this Non-Interference Agreement, will be effective unless in writing signed by the party to be charged.  Any subsequent change or changes in my duties, obligations, rights, or compensation will not affect the validity or scope of this Non-Interference Agreement.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:16.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">xv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Right of Continued Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  I acknowledge and agree that nothing contained herein shall be construed as granting me any right to continued employment by the Company, and the right of the Company to terminate my employment at any time with or without cause, is specifically reserved.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:13.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">xvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Non-Interference Agreement will be binding upon my heirs, executors, administrators, and other legal representatives and will be for the benefit of the Company, its successors, and its assigns.  I expressly acknowledge and agree that this Non-Interference Agreement may be assigned by the Company without my consent to any other member of the Company Group as well as any purchaser of all or substantially all of the assets or stock of the Company or of any business or division of the Company for which I provide services, whether by purchase, merger, or other similar corporate transaction, provided that the license granted pursuant to Section 2(a) may be assigned to any third party by the Company without my consent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-indent:9.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">xvii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Non-Interference Agreement shall survive the termination of my employment with the Company and&#47;or the assignment of this Non-Interference Agreement by the Company to any successor in interest or other assignee.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature to appear on the following page.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-9</font></div></div></div><div id="i0f76bd84b6c44083a8681975deb767aa_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> I, Tyson Murdock, have </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">executed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> this Confidentiality, Non-Interference, and Invention Assignment Agreement on the date set forth below&#58;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">June 25, 2020&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Tyson Murdock&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Signature)</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tyson Murdock&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.12pt;padding-left:2.16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Type&#47;Print Name)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Non-Interference Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="i0f76bd84b6c44083a8681975deb767aa_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SCHEDULE A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">LIST OF PRIOR DEVELOPMENTS</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND ORIGINAL WORKS OF AUTHORSHIP</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXCLUDED FROM SECTION 2</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.314%"><tr><td style="width:1.0%"></td><td style="width:33.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Title</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Date</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Identifying Number or Brief Description</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">___&#160;&#160;&#160;&#160;No Developments or improvements</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____&#160;&#160;&#160;&#160;Additional Sheets Attached</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signature of Executive&#58; _______________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Print Name of Executive&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> Tyson Murdock&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; June 25, 2020</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font><br></font></div></div></div><div id="i0f76bd84b6c44083a8681975deb767aa_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit B</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">RELEASE OF CLAIMS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As used in this Release of Claims (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the term &#8220;claims&#8221; will include all claims, covenants, warranties, promises, undertakings, actions, suits, causes of action, obligations, debts, accounts, attorneys&#8217; fees, judgments, losses, and liabilities, of whatsoever kind or nature, in law, in equity, or otherwise.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For and in consideration of the Severance Benefits (as defined in my Employment Agreement, dated June 25, 2020, with HealthEquity, Inc. (such corporation, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and such agreement, my&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)), and other good and valuable consideration, I, Tyson Murdock, for and on behalf of myself and my heirs, administrators, executors, and assigns, effective as of the date on which this release becomes effective pursuant to its terms, do fully and forever release, remise, and discharge each of the Company, and its respective direct and indirect parents, subsidiaries and affiliates, and their respective successors and assigns, together with their respective current and former officers, directors, partners, members, shareholders, employees, and agents (collectively, and with the Company, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), from any and all claims whatsoever up to the date hereof that I had, may have had, or now have against the Group, whether known or unknown, for or by reason of any matter, cause, or thing whatsoever, including any claim arising out of or attributable to my employment or the termination of my employment with the Company, whether for tort, breach of express or implied employment contract, intentional infliction of emotional distress, wrongful termination, unjust dismissal, defamation, libel, or slander, or under any federal, state, or local law dealing with discrimination based on age, race, sex, national origin, handicap, religion, disability, sexual orientation, or any other class protected under applicable law.  The release of claims in this Release includes, but is not limited to, all claims arising under the Age Discrimination in Employment Act of 1967 (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Civil Rights Act of 1991, the Family and Medical Leave Act of 1993, the Employee Retirement Income Security Act of 1974, the Worker Adjustment and Retraining Notification Act of 1988, and the Equal Pay Act of 1963, each as may be amended from time to time, and all other federal, state, and local laws, the common law, and any other purported restriction on an employer&#8217;s right to terminate the employment of employees.  I intend this Release contained herein to be a general release of any and all claims to the fullest extent permissible by law and for the provisions regarding the release of claims against the Group to be construed as broadly as possible, and hereby incorporate in this release similar federal, state or other laws, all of which I also hereby expressly waive.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I understand and agree that claims or facts in addition to or different from those which are now known or believed by me to exist may hereafter be discovered, but it is my intention to fully and forever release, remise and discharge all claims which I had, may have had, or now have against the Group, whether known or unknown, suspected or unsuspected, asserted or unasserted, contingent or noncontingent, without regard to the subsequent discovery or existence of such additional or different facts.  Without limiting the foregoing, by signing this Release, I expressly waive and release any provision of law that purports to limit the scope of a general release.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I acknowledge and agree that as of the date I execute this Release, I have no knowledge of any facts or circumstances that give rise or could give rise to any claims under any of the laws listed in the preceding paragraphs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By executing this Release, I specifically release all claims relating to my employment and its termination under the ADEA, a United States federal statute that, among other things, prohibits discrimination on the basis of age in employment and employee benefit plans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding any provision of this Release to the contrary, by executing this Release, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nothing in this Release shall be a waiver of&#58; (i)&#160; my rights arising out of breach of this Release&#59; (ii) my rights with respect to payment of the Severance Benefits&#59; (iii)&#160;my right to accrued, vested benefits due to terminated employees under any employee benefit plan of the Company or any other member of the Company Group in which I participated (excluding any severance or similar plan or policy), in accordance with the terms thereof (including my rights to elect continued medical and health benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985)&#59; (iv)&#160;any claims that cannot be waived by law&#59; (v)&#160;my right to indemnification, advancement and reimbursement of legal fees and expenses, and directors and officers liability insurance, as provided by, and in accordance with the terms of, applicable law, the Company&#8217;s governing documents or that certain Indemnification Agreement, dated June 27, 2017, by and between myself and the Company&#59; (vi)&#160;any rights or claims under the ADEA challenging the knowing and voluntary nature of this Release or that may arise after the date that I execute this Release&#59; or (vi)&#160;my rights as a stockholder of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I acknowledge and agree that as of the date of this Release, I have reported all accidents, injuries or illnesses relating to or arising from my employment with the Company or the Company Group and that I have not suffered any on-the-job injury or illness for which I have not yet filed a claim.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I expressly acknowledge and agree that I &#8211; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Am able to read the language, and understand the meaning and effect, of this Release&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Have no physical or mental impairment of any kind that has interfered with my ability to read and understand the meaning of this Release or its terms, and that I am not acting under the influence of any medication, drug, or chemical of any type in entering into this Release&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Am specifically agreeing to the terms of the release contained in this Release because the Company has agreed to pay me the Severance Benefits in consideration for my agreement to accept it in full settlement of all possible claims I might have or ever have had, and because of my execution of this Release&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Acknowledge that, but for my execution of this Release, I would not be entitled to the Severance Benefits&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Understand that, by entering into this Release, I do not waive rights or claims under the ADEA that may arise after the date I execute this Release&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Had or could have had &#91;twenty-one (21)&#93;&#91;forty-five (45)&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> calendar days from the date of my termination of employment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Release Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in which to review and consider this Release, and that if I execute this Release prior to the Release Expiration Date, I have voluntarily and knowingly waived the remainder of the review period&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Have seven (7) days to revoke my signature to the Release, which revocation period is not waivable, and which revocation must be received by the Company&#8217;s General Counsel by no later than the end of the 7-day revocation period&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Have not relied upon any representation or statement not set forth in this Release or my Employment Agreement made by the Company or any of its representatives&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Was advised to consult with my attorney regarding the terms and effect of this Release&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.9pt">Have signed this Release knowingly and voluntarily.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I represent and warrant that I have not previously filed, and to the maximum extent permitted by law agree that I will not file, a complaint, charge, or lawsuit against any member of the Group regarding any of the claims released herein.  If, notwithstanding this representation and warranty, I have filed or file such a complaint, charge, or lawsuit, I agree that I shall cause such complaint, charge, or lawsuit to be dismissed with prejudice and shall pay any and all costs required in obtaining dismissal of such complaint, charge, or lawsuit, including without limitation the attorneys&#8217; fees of any member of the Group against whom I have filed such a complaint, charge, or lawsuit.  This paragraph shall not apply, however, to a claim of age discrimination under the ADEA or to any non-waivable right to file a charge with the United States Equal Employment Opportunity Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">EEOC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or similar state agency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if the EEOC or similar state agency were to pursue any claims relating to my employment with the Company, I agree that I shall not be entitled to recover any monetary damages or any other remedies or benefits as a result and that this Release and Section 8 of my Employment Agreement will control as the exclusive remedy and full settlement of all such claims by me.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I hereby agree to waive any and all claims to re-employment with the Company or any other member of the Group and affirmatively agree not to seek further employment with the Company or any other member of the Group.  I acknowledge that if I re-apply for or seek employment with the Company or any other member of the Group, the Company&#8217;s or any other member of the Group&#8217;s refusal to hire me based on this provision will provide a complete defense to any claims arising from my attempt to apply for employment.</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be selected based on whether applicable termination was &#8220;in connection with an exit incentive or other employment termination program&#8221; (as such phrase is defined in the Age Discrimination in Employment Act of 1967).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything contained herein to the contrary, this Release will not become effective or enforceable prior to the expiration of the period of seven (7) calendar days immediately following the date of its execution by me (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Revocation Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), during which time I may revoke my acceptance of this Release by notifying the Company and the Board of Directors of the Company, in writing, delivered to the Company at its principal executive office, marked for the attention of its General Counsel.  To be effective, such revocation must be received by the Company no later than 11&#58;59&#160;p.m. on the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) calendar day following the execution of this Release.  Provided that this Release is executed and I do not revoke it during the Revocation Period, the eighth (8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) calendar day following the date on which this Release is executed shall be its effective date.  I acknowledge and agree that if I revoke this Release during the Revocation Period, this Release will be null and void and of no effect, and neither the Company nor any other member of the Group will have any obligations to pay me the Severance Benefits.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The provisions of this Release shall be binding upon my heirs, executors, administrators, legal personal representatives, and assigns.  If any provision of this Release shall be held by any court of competent jurisdiction to be illegal, void, or unenforceable, such provision shall be of no force or effect.  The illegality or unenforceability of such provision, however, shall have no effect upon and shall not impair the enforceability of any other provision of this Release.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXCEPT WHERE PREEMPTED BY FEDERAL LAW, THE VALIDITY, INTERPRETATION, CONSTRUCTION, AND PERFORMANCE OF THIS RELEASE IS GOVERNED BY AND IS TO BE CONSTRUED UNDER THE LAWS OF THE STATE OF UTAH APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT STATE, WITHOUT REGARD TO CONFLICT OF LAWS RULES.  ANY DISPUTE OR CLAIM ARISING OUT OF OR RELATING TO THIS RELEASE OR CLAIM OF BREACH HEREOF SHALL BE BROUGHT EXCLUSIVELY IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH, TO THE EXTENT FEDERAL JURISDICTION EXISTS, AND IN ANY COURT SITTING IN SALT LAKE CITY, UTAH, BUT ONLY IN THE EVENT FEDERAL JURISDICTION DOES NOT EXIST, AND ANY APPLICABLE APPELLATE COURTS.  BY EXECUTION OF THIS RELEASE, I CONSENT TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS, AND WAIVE ANY RIGHT TO CHALLENGE JURISDICTION OR VENUE IN SUCH COURT WITH REGARD TO ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS RELEASE.  FURTHER, I HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS RELEASE.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Capitalized terms used, but not defined herein, shall have the meanings ascribed to such terms in my Employment Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I, Tyson Murdock, have executed this Release of Claims on the date set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Tyson Murdock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:0.12pt;padding-left:2.16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tyson Murdock</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; June 25, 2020</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B-5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hqy-20210401.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0217b3d3-a373-4058-bbd4-1bd9038d62e9,g:1a9318c4-f7e3-4f6e-81d8-6a97cfe816dc-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hqy="http://healthequity.com/20210401" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://healthequity.com/20210401">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20210401_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20210401_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20210401_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20210401_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://healthequity.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>hqy-20210401_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0217b3d3-a373-4058-bbd4-1bd9038d62e9,g:1a9318c4-f7e3-4f6e-81d8-6a97cfe816dc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthequity.com/role/CoverPage" xlink:type="simple" xlink:href="hqy-20210401.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/CoverPage" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>hqy-20210401_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0217b3d3-a373-4058-bbd4-1bd9038d62e9,g:1a9318c4-f7e3-4f6e-81d8-6a97cfe816dc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://healthequity.com/role/CoverPage" xlink:type="simple" xlink:href="hqy-20210401.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/CoverPage" xlink:type="extended" id="i8e9e7669f00d48459711305b32348e0b_CoverPage"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>hqy-20210401_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0217b3d3-a373-4058-bbd4-1bd9038d62e9,g:1a9318c4-f7e3-4f6e-81d8-6a97cfe816dc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_58f74c09-8620-42ca-a0fa-d0e9c3a5aeee_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_13312966-0945-4d13-9914-016fe11c5cc3_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a7e937f6-1b35-4f18-9e88-205fccc50359_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3648c32b-5080-4c4b-9ef2-a45c49921e1f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_f16c2ed3-43cd-4413-8720-080e1c0a0101_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_77afd194-bd0a-47b9-b419-d08a6269a6ac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d0c534c2-6847-4d9f-b568-3a02f663e4f1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_7c5a9ef9-c153-43d7-bcec-5f1db3cc0f93_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_42ee86df-4d3b-40f6-a6a1-60d6eb2d08c9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_734bd55e-3eae-48f2-907d-011625d878f2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d392e903-5b39-4e81-b507-dd3db787c978_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_88a4afb3-ac14-4428-8073-5f1c811f27c4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_67d0976d-2cc9-4fc4-ad20-26afbb7d26e3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1eac7efd-8769-465e-b6a2-e15cced5aae6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9cb5d7f6-9e5b-4baf-bf43-d84bc7f8edbe_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5d1858de-4321-4e5d-8428-89fe60571cd0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4c81aae4-290e-42bb-b991-2cfb7f6350ab_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_25625233-3830-4039-8453-769067865e3a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_68d76309-0b7b-46e2-b068-2d4e1d88ea1e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_102e2f7d-1be8-4b06-a8b6-a01283539c57_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8a54cc7e-ef3d-4790-a898-475bfde4b48b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_0ee1b665-8a30-4183-89d6-3efb0cae3f47_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7dd70836-d892-4c81-b83f-69d7558123f5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_94d51113-08a9-4fc7-956c-47043dc5fec4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>hqy-20210401_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0217b3d3-a373-4058-bbd4-1bd9038d62e9,g:1a9318c4-f7e3-4f6e-81d8-6a97cfe816dc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthequity.com/role/CoverPage" xlink:type="simple" xlink:href="hqy-20210401.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3d8383ab-bf0e-41e2-8fa9-b04f71d10f5f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_DocumentType_3d8383ab-bf0e-41e2-8fa9-b04f71d10f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4f15b70f-0bc6-44cf-afda-36e84c72bc2f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_DocumentPeriodEndDate_4f15b70f-0bc6-44cf-afda-36e84c72bc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b3fe88c4-5104-4dc2-a97a-0567ef5bca66" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityFileNumber_b3fe88c4-5104-4dc2-a97a-0567ef5bca66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5aed3b41-1ade-440b-adf1-aaf2be58566d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityRegistrantName_5aed3b41-1ade-440b-adf1-aaf2be58566d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c3c0a092-6d32-4e23-bf3d-64ef25887f81" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c3c0a092-6d32-4e23-bf3d-64ef25887f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3ee18a9c-b4ea-4841-9399-ddefa6e88a28" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityTaxIdentificationNumber_3ee18a9c-b4ea-4841-9399-ddefa6e88a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e70d0191-8627-4d09-bd64-48eabdff2d08" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityAddressAddressLine1_e70d0191-8627-4d09-bd64-48eabdff2d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_59e5c35d-6b4e-40cf-9d82-83162a41e7de" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityAddressAddressLine2_59e5c35d-6b4e-40cf-9d82-83162a41e7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0bd918d2-0709-4853-92b2-25195649b9ac" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityAddressCityOrTown_0bd918d2-0709-4853-92b2-25195649b9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_aed608a0-edb8-4596-aef0-ba9f1615ef7e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityAddressStateOrProvince_aed608a0-edb8-4596-aef0-ba9f1615ef7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a5864197-d0c2-4732-b377-197c785c5f21" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityAddressPostalZipCode_a5864197-d0c2-4732-b377-197c785c5f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fe982d85-b157-4ada-9ae6-bac569d008e3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_CityAreaCode_fe982d85-b157-4ada-9ae6-bac569d008e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cfa63f13-1b57-429d-b53a-dcf5330d6681" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_LocalPhoneNumber_cfa63f13-1b57-429d-b53a-dcf5330d6681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_4573a2f7-ea15-4c31-965b-488bd5e8fcfa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_WrittenCommunications_4573a2f7-ea15-4c31-965b-488bd5e8fcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b28fc889-203e-4fa5-8d8c-d83877cc654c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_SolicitingMaterial_b28fc889-203e-4fa5-8d8c-d83877cc654c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_05bd832c-8e1d-4e5b-97e1-ba2e167ab9cf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_PreCommencementTenderOffer_05bd832c-8e1d-4e5b-97e1-ba2e167ab9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_903061c5-3b06-4577-9dfe-1b3b4f811828" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_903061c5-3b06-4577-9dfe-1b3b4f811828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d7efe0d2-8727-4a4d-b984-11ad5d191866" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_Security12bTitle_d7efe0d2-8727-4a4d-b984-11ad5d191866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a4cb3963-3935-4ad7-9c72-d51a45a853ec" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_TradingSymbol_a4cb3963-3935-4ad7-9c72-d51a45a853ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_dbdec9c2-efac-4988-ae29-8a3ceeb75a2b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_SecurityExchangeName_dbdec9c2-efac-4988-ae29-8a3ceeb75a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9bfdb330-50d0-4cdf-b7ff-b7d0c51b6531" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityEmergingGrowthCompany_9bfdb330-50d0-4cdf-b7ff-b7d0c51b6531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bf3ba901-60bb-412e-a5ea-4dde2047bf1c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_EntityCentralIndexKey_bf3ba901-60bb-412e-a5ea-4dde2047bf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_22a9aed7-0732-44a6-a4d2-e21cf5292d2b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5e7df64-e067-4fc0-b3f8-7d881b7661d7" xlink:to="loc_dei_AmendmentFlag_22a9aed7-0732-44a6-a4d2-e21cf5292d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>hqy-20210401_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hqy-20210401.xsd" xlink:type="simple"/>
    <context id="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV80L2ZyYWc6MTFhNTE2NDNkZjdjNDZiMWFiZjQwY2M0ZTczN2ZhMjkvdGFibGU6YjdiOTBiY2I1MjQ4NDdjYjkxYTY3ZjY2NTljYWM2ZDUvdGFibGVyYW5nZTpiN2I5MGJjYjUyNDg0N2NiOTFhNjdmNjY1OWNhYzZkNV8yLTEtMS0xLTA_8241c5d1-c023-4d98-b283-4d5b4db98b4b">0001428336</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV80L2ZyYWc6MTFhNTE2NDNkZjdjNDZiMWFiZjQwY2M0ZTczN2ZhMjkvdGFibGU6YjdiOTBiY2I1MjQ4NDdjYjkxYTY3ZjY2NTljYWM2ZDUvdGFibGVyYW5nZTpiN2I5MGJjYjUyNDg0N2NiOTFhNjdmNjY1OWNhYzZkNV8zLTEtMS0xLTA_5492da65-eed3-4857-a918-22e06cb0bcaf">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF84Mw_20764cdf-05ed-4432-9b9c-22e523a9bc17">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yMjU_a2a96eaa-40a0-4ba6-9381-f29dea388d54">2021-04-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6MjliZDRlOTQwMjNhNDczYzhlNmNkODE5ZWZiODg1NjYvdGFibGVyYW5nZToyOWJkNGU5NDAyM2E0NzNjOGU2Y2Q4MTllZmI4ODU2Nl8xLTAtMS0xLTA_5b8e1041-0bf0-40ea-8030-430406251b4e">HEALTHEQUITY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6YjQwYjI5MDUyOGY5NGEwMTljNjM4NjdmNjQ2MmJhMzEvdGFibGVyYW5nZTpiNDBiMjkwNTI4Zjk0YTAxOWM2Mzg2N2Y2NDYyYmEzMV8wLTAtMS0xLTA_1bf2f753-21c7-4a9c-92d3-458b51b9f114">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6YjQwYjI5MDUyOGY5NGEwMTljNjM4NjdmNjQ2MmJhMzEvdGFibGVyYW5nZTpiNDBiMjkwNTI4Zjk0YTAxOWM2Mzg2N2Y2NDYyYmEzMV8wLTItMS0xLTA_1baad480-aae8-4c29-896f-8a0afe4f6ecb">001-36568</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6YjQwYjI5MDUyOGY5NGEwMTljNjM4NjdmNjQ2MmJhMzEvdGFibGVyYW5nZTpiNDBiMjkwNTI4Zjk0YTAxOWM2Mzg2N2Y2NDYyYmEzMV8wLTQtMS0xLTA_c6bff5e9-b6ba-404e-b9d7-c0798e5cac5f">52-2383166</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yMzc_756eabbb-7e1d-4acd-a835-ca405b25e180">15 West Scenic Pointe Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNDE_a615dafd-dfdf-4b8e-9fa3-4ecb291c52bb">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNDU_ebd0996c-6214-45c8-bcd7-68f80edae05e">Draper</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNDk_28780fd8-c1a7-42c2-84b1-1208ca5b7ebb">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNTI_631ae561-5aa0-439a-b7f0-ca180b499db0">84020</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNTc_4e1d3944-ee68-43a0-b52b-433c4ae251ac">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8yNjE_e7fd2d07-081b-4255-b562-5c467ca25646">727-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF82Njc_2a311fa3-3388-4be2-adf0-497a3dbc3a77">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF83NTY_1791ba19-e5a4-46b8-86ee-995244877d11">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF84NDY_47e532a4-437a-4772-aed6-e7e2570a4ae8">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF85NTI_d119c695-53e9-406f-92ab-082e58970f5c">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6OGVlMDk1ZWI4NmRiNGMwYThmMmI2NWU0MDlmMzcxODkvdGFibGVyYW5nZTo4ZWUwOTVlYjg2ZGI0YzBhOGYyYjY1ZTQwOWYzNzE4OV8xLTAtMS0xLTA_b44c2da9-4ee7-4c1a-9206-3740bf509f1d">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6OGVlMDk1ZWI4NmRiNGMwYThmMmI2NWU0MDlmMzcxODkvdGFibGVyYW5nZTo4ZWUwOTVlYjg2ZGI0YzBhOGYyYjY1ZTQwOWYzNzE4OV8xLTEtMS0xLTA_469d008b-6ad8-4e26-b09f-73a9c18db93a">HQY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGFibGU6OGVlMDk1ZWI4NmRiNGMwYThmMmI2NWU0MDlmMzcxODkvdGFibGVyYW5nZTo4ZWUwOTVlYjg2ZGI0YzBhOGYyYjY1ZTQwOWYzNzE4OV8xLTItMS0xLTA_53395819-c4b7-4bc1-802c-048f6b4eb55e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i16b28992f16b40ffaf754d637480ffad_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOjc1NzJkNWUzMjE5YjQ5OGZhMjBiZTUxMzdjOTNiZGI5L3NlYzo3NTcyZDVlMzIxOWI0OThmYTIwYmU1MTM3YzkzYmRiOV8xL2ZyYWc6MWYxZTdiMjFlYTc1NDcwZDk1N2NiYjdiMTBhOGQ1MDQvdGV4dHJlZ2lvbjoxZjFlN2IyMWVhNzU0NzBkOTU3Y2JiN2IxMGE4ZDUwNF8xMzY2_a673c8c4-271e-45e9-a959-3af10a1f5529">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140362952100808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  01,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HEALTHEQUITY, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2383166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 West Scenic Pointe Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Draper<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HQY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001428336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M))S=K@4'PW ?P/NEUO:MX8[#^7\S^O\!4$L#!!0    ( %"$@5*?H!OPL0(
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M/[&\UDX:?^:+X3]>?P%02P$"% ,4    " !0A(%2!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %"$
M@5)041NS[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( %"$@5*97)PC$ 8  )PG   3              "
M <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 4(2!4FBLZ)M0
M!   V1   !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( %"$@5*?H!OPL0(  .(,   -              "
M 9,,  !X;"]S='EL97,N>&UL4$L! A0#%     @ 4(2!4I>*NQS     $P(
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9>&UL4$L%!@     )  D /@(  .L3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hqy-20210401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="hqy-20210401.htm">hqy-20210401.htm</File>
    <File>exhibit101-tysonmurdockemp.htm</File>
    <File>hqy-20210401.xsd</File>
    <File>hqy-20210401_cal.xml</File>
    <File>hqy-20210401_def.xml</File>
    <File>hqy-20210401_lab.xml</File>
    <File>hqy-20210401_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hqy-20210401.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "hqy-20210401_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hqy-20210401_def.xml"
     ]
    },
    "inline": {
     "local": [
      "hqy-20210401.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hqy-20210401_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hqy-20210401_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hqy-20210401.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hqy",
   "nsuri": "http://healthequity.com/20210401",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20210401.htm",
      "contextRef": "i16b28992f16b40ffaf754d637480ffad_D20210401-20210401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://healthequity.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20210401.htm",
      "contextRef": "i16b28992f16b40ffaf754d637480ffad_D20210401-20210401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001428336-21-000013-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001428336-21-000013-xbrl.zip
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MX%DP+?)Y4,%:2"N"_SX<2?ROQXMQJXOQ#F%$SDD/[-==X,3%O.Y*%B23@-$
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M97XN#0DL"K9&PVT-N+W,>^/G&OPA'" 4KAY^;Y2DQ))Y<]22I1H$7\J/2U&
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M(-NUX5HWHM@_-1^$QR[9TWAC$O6L)>KY'O$/_H[MA99>* :#%\*C@;D="28
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M;XZ'^'/SAHO@P^!P2 /SJ#(?&/7H!(89C'B<,/AT-'I_^G$4G _?#<[I:9C
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MUD90/# *YLC1)@J>#9>IA-0(*W058@>;4'JI:N1.C=<9U?!WD?P[<K?*MH^
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M($0>(O)'DL+4NS42":SQ,I]6Z 8)W8-"3')MQI:T;ZA/(7'A1M5IA!#I>$+
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M$QFCQ_-0K+@OT^*-XAXZZCD=\)9F:)CJA*(->$NR2%%:("TVS00X5TF%TQ:
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MC1SQUTT?EG[:09@6U72@ >IZ?@L51&OD3D[D2G"B&KK!$SDZ,JR+3$A[13P
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MFNS-H=UTSA7;5DS2*)FWB,+5I? !U%C81!22OP9!6>;JRJ1D'E&TP(L34%+
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M4*^U#,(@SI8;'6H#FN^QM$LKIM6I.ZV.\L7C)[Z>/U[F%]]02P,$%     @
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MGBDSES+98)7-5DPGJ/3+?%-]^NRR!P<NLS7DSL)>O \E?7[FXB=;R+-OJMD
MNKJFY"BT(>FJHTJF;BL2Z'73H8;=8(@!1RD=7A?_%Q*T_0B6,SCQ)V\VJ/P=
M2]3O?*MK"F5&79$,BODEFD4EN^')H/5!W=NZ9;DV:'U3E]6W M%KS\@Z",M;
M,:,_);,XWW2P##5+UR7&ZB8P"W",#7H</FF.3IEJ*-0!9I&OI2"]>TYYWHW
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M<VQQG.<>1Y"KJ\[_N5.^?S]-^($#/S]=D^6B9E'!2#AK-AO2P,NWYT2:KRB
M;M84DSAY<W0*WGD,DW.O.TZOW#JWP% VE<<8Y[I5:YCJDQOGC9IIWN].K(<]
MJ\M//U;-K*GJDU[@=>-+&:VW88Q7-C^WMW;[G]M?CCK]095T>MNU?Y;E#>J=
M-<MGQ9[1I'FY>7V<-Q\PCV=\>>C+37D]62?XGOHP(KLPV,?PZ3^"#GA_S1,O
M_F-O%GHE%'EU7/%\*+Z: /P*NA\+""\]Y?;7_>KB31;;T31,6,#]<K R8Y;2
M>'Z/^X7^29<6K-N1.X=_ANDXV/Q_4$L#!!0    ( %"$@5+*CR(9C@(  '\)
M   0    :'%Y+3(P,C$P-# Q+GAS9-U676_:,!1]YU=X>9[S01B0J%!IK2I-
M8A_J6K5ODQ/?)%83.]A.@7\_QY!!:+N5:0_;)"22ZW..[[G7'SD[7U<E>@2I
MF. S)W!]!P%/!64\GSFW-U=XZIS/!X.S-QC?O[]>H$N1-A5PC2XD$ T4K9@N
MT!T%]8 R*2IT)^0#>R08SRWI0M0;R?)"HZ$_#(Y'96R"DR2D(2;A),0C_]T4
M)PD=X2"AD1].Z7@(T=L\#D@4!M-TA+,)&%@V!CP-Z!2/231),Y@&8YI:T;6*
M55I 19 QQE6\5C.GT+J./6^U6KFKT!4R]X:^'WCW'Q=?+=3984O&'WKH=2++
M#A]Z[7!"%'3P8KGY@2Z E+J 9</TQDU%Y;5N_9$?.(AH+5G2:+@2LKJ$C#2E
MGCD-7S:D9!D#:BI>0EO3'N!@6!.9@_Y$*E U2>$5D\X'"+6E8%4MI$;\"?6@
M%D$41=ZZ->>@;>D6(B7:KH<7:V'QN'W$P1"'@;M6U/%>-6U?B'&E"4_AE+G-
M&^YX?R*'?6-/RZ'CG9Z#%5.0NKEX]"@P(QI$V ^,PO-)J)=([0/>L_OS$\Z%
MMBIM9!>K:\8SL0V84&LB[IQ<0];MFR>;X9GE8O]B(E,IRE^L+:^6H@:I&:C#
MC60%"@F982\WN%O WTJ2N":1#O%$O]^-=M@S%"@7>R,=5V]JPU6F%R5L2_,7
M^TY)>:IO0TF;TG;Y7W=/(3O5O:$PSOX'\[6$4\T;BC+WQN_TON7?F''$Z,RY
M$.8+X O)37IM_/;ZP\MWC)UX3^A4.]U]/^:^N63-#^']1P-&EHE:ZIEW3#B2
M:A30SWQNGX^=[L@[R$^(1[OCU;S^NGJ6M@MVE=P=L5[_C-V^'YS#-K ]XN>#
M[U!+ P04    " !0A(%2P$:K&84!  #1 @  %    &AQ>2TR,#(Q,#0P,5]C
M86PN>&ULG9)1;]L@$,??\RF8^SJ,L;/$MI)4:J9)DS*IRE:UKQC.-HH-*9#:
M^?8SK$VUK=6DO8#N[G?WOSM878]]AY[ 6*G5.J)Q$B%07 NIFG5T]^,+SJ/K
MS6RV^H#QP\U^ASYK?NI!.;0UP!P(-$C7HGL!]H!JHWMTK\U!/C&,-R%IJX]G
M(YO6H31)Z9]14T[.996)#+-LF>%Y\BG'527FF%:B2+)<+%(H/C8E945&<S['
M]1(FK%X SJG(\8(52UY#3A>"AZ*=5(?2'Q6S@*;AE WF.FJ=.Y:$#,,0CY7I
M8FT:DB9)1E[HZ!D?_^*'+-"T* H2HA?4RK? J2PE#]]VWWD+/<-26<<4]P)6
MEC8X=YHS%W;^S[[0NX2W\ N&O0O3%&<T'JV(-C.$?JW#Z [V4"-_W^V_7B1;
M8)UKX?$DW3GFNB<>(%L]?8=;UOAV0[H['V$=6=D?NXNO-5!/=1[/V#]K,D^"
MYM5K+GF5YZSCIRY,NYOLYPI>Z_\Z@=&!$B"\QHK\]N";V4]02P,$%     @
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M"[=E]DXRK4NUAS(K[@838UT2Z_JK_;R#Y-)?)GLGYWDF5#X."97:]PT@1AA
M680!AZ&VA*  ^YJ%]IW6FEOW?'*B*\!Y-V)BSAT45^&JA>2Z,G!LS97)_W>%
M['\'4EU=MGUD5_$WG.[JTJ@(K]:@ZUKWPB36T?1CHLW]O\W#6!..#8<$^))P
M0 U#=EZ%(="::!FR4/&0N:US-R*<FA*7*[<E2J^$Z5F<KFO;32+;KFM[T#/,
MFK8],QW6L@W9]U[';OH=> W;D-;V^K7)L*N<K\3]1VU]QM%R)]NGVYDTV9@Q
M044D"1 *44 I9H#!D!3CJV((13A4U$W6#9%.5-X6K5>%ZRWPNLJ\B>"V<C\
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M=/_#L?_JOU!+ 0(4 Q0    ( %"$@5+J(O)6GW0  ,D< P >
M  "  0    !E>&AI8FET,3 Q+71Y<V]N;75R9&]C:V5M<"YH=&U02P$"% ,4
M    " !0A(%25U&;-2T>  #2HP  $               @ ';=   :'%Y+3(P
M,C$P-# Q+FAT;5!+ 0(4 Q0    ( %"$@5+*CR(9C@(  '\)   0
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M4$L! A0#%     @ 4(2!4I@0+][:!@  D3,  !0              ( !Y:0
K &AQ>2TR,#(Q,#0P,5]P<F4N>&UL4$L%!@     '  < T $  /&K      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
